SCHEMBL22549941

SCHEMBL22549941

CC1(CN2CCC(N)CC2)CCC1

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 1/20 0.39
GNAO1 P09471 1/20 0.39
GNAI1 P63096 1/20 0.39
SPHK1 Q9NYA1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22874820 0.77
SCHEMBL24837676 0.77
SCHEMBL22722883 0.76 TSHR (0.38)
SCHEMBL24219555 0.76
SCHEMBL22875125 0.74 KDM4E (0.30)
SCHEMBL6602752 0.73 TSHR (0.35)
SCHEMBL22969999 0.73 TSHR (0.32)
SCHEMBL22875126 0.73 ACHE (0.32)
SCHEMBL22874821 0.73
SCHEMBL24139224 0.73 HTT (0.33) GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020210630-A1 TRICYCLIC DEGRADERS OF IKAROS AND AIOLOS C4 THERAPEUTICS, INC. (US) 2020-10-15 WO disclosed